Who owns AKBA?
Institutional ownership of Akebia Therapeutics Inc. from Form 13F, Q2 2026
170 institutional managers reported holding Akebia Therapeutics Inc. (AKBA) in Form 13F filings for Q2 2026, with 109,967,017 shares worth $125M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 8,275,760 shares (+8.1%). 36 opened new positions and 36 sold out.
- Funds holding
- 170
- Value held
- $125M
- New / sold out
- 36 / 36
- Net shares, same filers
- +8.1%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AKBA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $22.8M | 18.2% | 19,986,374 | Added |
| Vanguard Capital Management LLC | $12.9M | 10.3% | 11,322,143 | Added |
| AQR Capital Management LLC | $10.4M | 8.3% | 9,151,524 | Added |
| Geode Capital Management, LLC | $7.7M | 6.1% | 6,727,302 | Added |
| State Street Corp | $6.1M | 4.9% | 5,390,853 | Trimmed |
| Jacobs Levy Equity Management, Inc | $4.9M | 3.9% | 4,273,026 | Added |
| Nantahala Capital Management, LLC | $4.6M | 3.6% | 4,000,000 | Added |
| Acadian Asset Management LLC | $4.6M | 3.6% | 4,004,867 | Added |
| Goldman Sachs Group Inc | $4.2M | 3.4% | 3,689,167 | Added |
| Millennium Management LLC | $3.6M | 2.9% | 3,196,605 | Added |
| Vanguard Portfolio Management LLC | $2.9M | 2.3% | 2,533,977 | Added |
| Two Sigma Investments, LP | $2.8M | 2.2% | 2,436,673 | Added |
| Charles Schwab Investment Management Inc | $2.6M | 2.1% | 2,300,438 | Added |
| Northern Trust Corp | $2.5M | 2.0% | 2,160,365 | Added |
| Vanguard Fiduciary Trust Co | $2.2M | 1.7% | 1,908,797 | Added |
| FMR LLC | $2.1M | 1.7% | 1,871,059 | Added |
| Qube Research & Technologies Ltd | $2.0M | 1.6% | 1,779,707 | Trimmed |
| Citadel Advisors LLC | $2.0M | 1.6% | 1,717,659 | Added |
| UBS Group AG | $1.6M | 1.3% | 1,374,950 | Added |
| Renaissance Technologies LLC | $1.4M | 1.1% | 1,223,963 | Trimmed |
| Citigroup Inc | $1.3M | 1.0% | 1,124,570 | Trimmed |
| Hennion & Walsh Asset Management, Inc. | $957K | 0.8% | 839,729 | Added |
| Morgan Stanley | $800K | 0.6% | 701,540 | Added |
| Invesco Ltd. | $792K | 0.6% | 694,928 | Trimmed |
| Mangrove Partners Im, LLC | $760K | 0.6% | 666,954 | Added |
Share of 13F holdings is each fund's shares as a share of the 109,967,017 AKBA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- AQR Capital Management LLC Added+$8.4M
- Jacobs Levy Equity Management, Inc Added+$4.4M
- Acadian Asset Management LLC Added+$3.0M
- Nantahala Capital Management, LLC Added+$2.3M
- BlackRock, Inc. Added+$1.5M
- Two Sigma Investments, LP Added+$1.3M
- Millennium Management LLC Added+$926K
- Ameriprise Financial Inc Added+$702K
- UBS Group AG Added+$690K
- Choreo, LLC New+$641K
Biggest sellers in Q2 2026
- State Street Corp Trimmed-$7.1M
- Bank of America Corp Trimmed-$2.6M
- Jane Street Group, LLC Sold out-$2.0M
- Citigroup Inc Trimmed-$2.0M
- HRT Financial LP Sold out-$1.4M
- Voleon Capital Management LP Sold out-$939K
- Qube Research & Technologies Ltd Trimmed-$702K
- Renaissance Technologies LLC Trimmed-$694K
- BNP Paribas Financial Markets Trimmed-$668K
- Dimensional Fund Advisors LP Trimmed-$641K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $32.6M and sold $24.5M; 69 added and 32 trimmed.
Schedule 13D and 13G filings on AKBA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-12STATE STREET CORP SCHEDULE 13G filed by Akebia Therapeutics Inc.Schedule 13G
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by Akebia Therapeutics Inc.Schedule 13G
- 2025-04-30VANGUARD GROUP INC SCHEDULE 13G filed by Akebia Therapeutics Inc.Schedule 13G
Questions about AKBA ownership
- Who owns AKBA stock?
- 170 institutional investment managers reported AKBA positions in their Form 13F filings for Q2 2026, holding 109,967,017 shares worth $125M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling AKBA?
- In Q2 2026, 36 managers opened new AKBA positions, 69 added, 32 trimmed and 36 sold out. Managers that filed in both quarters added a net 8,275,760 shares.
- How current is this AKBA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AKBA by CUSIP. Options are left out. AKBA news and filings · AKBA insider trades · Top funds